Xencor, Inc.
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that tar…
Biotechnology
US, Monrovia [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Xencor, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDXencor, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Xencor, Inc..
If you want to see a demo, head over to the financial segments of AAPL